Voices
Felipe Couñago: ENRT Plus Short-Term ADT Outperforms MDT Without QoL Impact in PEACE V–STORM
Felipe Couñago/genesiscare.com

Felipe Couñago: ENRT Plus Short-Term ADT Outperforms MDT Without QoL Impact in PEACE V–STORM

Felipe Couñago, Medical Director at GenesisCare Spain, shared a post on X about a recent article he and his colleagues co-authored, adding:

“New open-access results from PEACE V–STORM

Grateful to be a co-author. Special thanks to Thomas Zilli and Piet Ost.

ENRT + short-term ADT improves disease control vs MDT, with no QoL compromise.”

Title: Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V–STORM Randomized Trial

Authors: Thomas Zilli, Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, Fernando López Campos, Alexandros Papachristofilou, Matthias Guckenberger, Marta Scorsetti, Almudena Zapatero, Ana-Elena Villafranca Iturre, Clara Eito, Felipe Couñago, Paolo Muto, Wim Duthoy, Nicolas Mach, Valérie Fonteyne, Daniel Moon, Kristian Thon, Carole Mercier, Vérane Achard, Karin Stellamans, Els Goetghebeur, Dries Reynders, Piet Ost

Read the Full Article on European Urology Oncology

Felipe Couñago: ENRT Plus Short-Term ADT Outperforms MDT Without QoL Impact in PEACE V–STORM

More posts featuring Felipe Couñago.

 

Alexandros Papachristofilou Alfonso Gomez-Iturriaga Almudena Zapatero Ana-Elena Villafranca Iturre Antonio Conde-Moreno cancer Carole Mercier Clara Eito Daniel Moon Dries Reynders Els Goetghebeur Felipe Couñago Fernando López Campos François-Xavier Otte Karin Stellamans Kristian Thon Marta Scorsetti Matthias Guckenberger Mohamed Shelan Nick Liefhooghe Nicolas Mach OncoDaily Oncology Paolo Muto Piet Dirix Piet Ost Shankar Siva Sigmund Brabrand Thomas Zilli Valerie Fonteyne Verane Achard Wim Duthoy Wouter Everaerts